Nonlymphocyte-derived tumor necrosis factor is required for induction of colitis in recombination activating gene (RAG)2(-/-) mice upon transfer of CD4+CD45RB(hi) T cells

Journal of Experimental Medicine

Volumn 190, Issue 10, 1999, Pages 1479-1491

  Corazza, Nadia ^a   Eichenberger, Susanne ^a   Eugster, Hans Pietro ^b   Mueller, Christoph ^a,c  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c S   (Switzerland)

Author keywords

Inflammatory bowel disease; Intestinal inflammation; Mucosal immunity; Proinflammatory cytokines

Indexed keywords

CD4 ANTIGEN; CD5 ANTIGEN; CYTOKINE; GAMMA INTERFERON; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLITIS; COLON MUCOSA; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ACTIVITY; ENTERITIS; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RECOMBINANT GENE;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD45; CD4-POSITIVE T-LYMPHOCYTES; DNA-BINDING PROTEINS; INFLAMMATORY BOWEL DISEASES; INTERFERON TYPE II; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033571441     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.190.10.1479     Document Type: Article

References (49)

1. Elson, C.O., R.B. Sartor, G.S. Tennyson, and R.H. Riddell. 1995. Experimental models of inflammatory bowel disease. Gastroenterology. 109:1344-1367.
2. Mombaerts, P., E. Mizoguchi, M.J. Grusby, L.H. Glimcher, A.K. Bhan, and S. Tonegawa. 1993. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell. 75:274-282.
3. Sadlack, B., H. Merz, H. Schorle, A. Schimpl, A.C. Feller, and I. Horak. 1993. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell. 75:253-261.
4. Kühn, R., J. Lohler, D. Rennick, K. Rajewski, and W. Muller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 75:263-274.
5. Shull, M.M., I. Ormsby, A.B. Kier, S. Pawlowski, R.J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, et al. 1992. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature. 359:693-699.
6. Ehrhardt, R.O., B.R. Ludviksson, B. Gray, M. Neurath, and W. Strober. 1997. Induction and prevention of colonic inflammation in IL-2-deficient mice. J. Immunol. 158:566-573.
7. 4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease. J. Exp. Med. 187:855-864.
8. Holländer, G.A., B. Wang, A. Nichogiannopoulou, P.P. Platenburg, W. van Ewijk, S.J. Burakoff, J.-C. Gutierrez-Ramos, and C. Terhorst. 1995. Developmental control point in induction of thymic cortex regulated by a subpopulation of prothymocytes. Nature. 373:350-353.
9. 4+ T cells induce or protect from chronic intestinal inflammation in C.B-17 scid mice. Int. Immunol. 5:1461-1471.
10. 4+ T cells. J. Exp. Med. 178:237-244.
11. Autenrieth, I.B., N. Bucheler, E. Bohn, G. Heinze, and I. Horak. 1997. Cytokine mRNA expression in intestinal tissue of interleukin-2 deficient mice with bowel inflammation. Gut. 41:793-800.
12. Berg, D.J., N. Davidson, R. Kuhn, W. Muller, S. Menon, G. Holland, L. Thompson Snipes, M.W. Leach, and D. Rennick. 1996. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J. Clin. Invest. 98: 1010-1020.
13. Nielsen, O.H., T. Koppen, N. Rudiger, T. Horn, J. Eriksen, and I. Kirman. 1996. Involvement of interleukin-4 and -10 in inflammatory bowel disease. Dig. Dis. Sci. 41:1786-1793.
14. + T cells in an experimental model of colitis. Eur. J. Immunol 27:17-25.
15. + T cells. Immunity. 1:553-562.
16. Kojouharoff, G., W. Hans, F. Obermeier, D.N. Mannel, T. Andus, J. Scholmerich, V. Gross, and W. Falk. 1997. Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice. Clin. Exp. Immunol. 107:353-358.
17. MacDonald, T.T., P. Hutchings, M.J. Choy, S. Murch, and A. Cooke. 1990. Tumor necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clin. Exp. Immunol. 81:301-305.
18. Reinecker, H.C., M. Steffen, T. Witthoeft, I. Pflueger, S. Schreiber, R.P. MacDermott, and A. Raedler. 1993. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin. Exp. Immunol. 94:174-181.
19. Derkx, B., J. Taminiau, S. Radema, A. Stronkhorst, C. Wortel, G. Tytgat, and S. van Deventer. 1993. Tumour-necrosis-factor antibody treatment in Crohn's disease (letter). Lancet. 342:173-174.
20. van Dullemen, H.M., S.J. van Deventer, D.W. Hommes, H.A. Bijl, J. Jansen, G.N. Tytgat, and J. Woody. 1995. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology. 109:129-135.
21. Reimund, J.M., C. Wittersheim, S. Dumont, C.D. Muller, J.S. Kenney, R. Baumann, P. Poindron, and B. Duclos. 1996. Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease. Gut. 39:684-689.
22. Neurath, M.F., S. Pettersson, K.-H. Meyer zum Büschenfelde, and W. Strober. 1996. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NK-κB abrogates established experimental colitis in mice. Nat. Med. 2:998-1004.
23. Simpson, S.J., S. Shah, M. Comiskey, Y.P. de Jong, B. Wang, E. Mizoguchi, A.K. Bhan, and C. Terhorst. 1998. T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon γ expression by T cells. J. Exp. Med. 187:1225-1234.
24. Jung, H.C., L. Eckmann, S.K. Yang, A. Panja, J. Fierer, E. Morzycka-Wroblewska, and M.F. Kagnoff. 1995. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J. Clin. Invest. 95:55-65.
25. Amour, A., P.M. Slocombe, A. Webster, M. Butler, C.G. Knight, B.J. Smith, P.E. Stephens, C. Shelley, M. Hutton, V. Knauper, et al. 1998. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett. 435:39-44.
26. Mauri, D.N., R. Ebner, R.I. Montgomery, K.D. Kochel, T.C. Cheung, G.L. Yu, S. Ruben, M. Murphy, R.J. Eisenberg, G.H. Cohen, et al. 1998. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity. 8:21-30.
27. Pasparakis, M., L. Alexopoulou, V. Episkopou, and G. Kollias. 1996. Immune and inflammatory responses in TNF-α-deficient mice: a critical requirement for TNF-α in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Mud. 184:1397-1411.
28. Eugster, H.-P., M. Müller, U. Karrer, B.D. Car, B. Schnyder, V.M. Eng, G. Woerly, M. Le Hir, F. di Padova, M. Aguet, et al. 1996. Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-alpha double-deficient mice. Int. Immunol. 8:23-36.
29. Shinkai, Y., G. Rathbun, K.P. Lam, E.M. Oltz, V. Stewart, M. Mendelsohn, J. Charron, M. Datta, F. Young, A.M. Stall, et al. 1992. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell. 68: 855-867.
30. + cytotoxic cells are present in increased numbers in the intestinal mucosa from patients with active inflammatory bowel disease. Am. J. Pathol. 152:261-268.
31. Mueller, C., H.K. Gershenfeld, and I.L. Weissman. 1988. Activation of CTL-specific genes during cell-mediated cytolysis in vivo: expression of the HF gene analyzed by in situ hybridization. Immunol. Rev. 103:73-85.
32. Hunger, R.E., S. Muller, J.A. Laissue, M.W. Hess, C. Carnaud, I. Garcia, and C. Mueller. 1996. Inhibition of submandibular and lacrimal gland infiltration in nonobese diabetic mice by transgenic expression of soluble TNF-receptor p55. J. Clin. Invest. 98:954-961.
33. McDonald, S.A., M.J. Palmen, E.P. Van Rees, and T.T. MacDonald. 1997. Characterization of the mucosal cell-mediated immune response in IL-2 knockout mice before and after the onset of colitis. Immunology. 91:73-80.
34. Cope, A.P., R.S. Liblau, X.D. Yang, M. Congia, C. Laudanna, R.D. Schreiber, L. Probert, G. Kollias, and H.O. McDevitt. 1997. Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling. J. Exp. Med. 185:1573-1584.
35. Liu, J., M.W. Marino, G. Wong, D. Grail, A. Dunn, J. Bettadapura, A.J. Slavin, L. Old, and C.C. Bernard. 1998. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat. Med. 4:78-83.
36. Neurath, M.F., I. Fuss, M. Pasparakis, L. Alexopoulou, S. Haralambous, K.-H. Meyer zum Büschenfelde, W. Strober, and G. Kollias. 1997. Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice. Eur. J. Immunol. 27:1743-1750.
37. Baumgart, D.C., W.A. Olivier, T. Reya, D. Peritt, J.L. Rombeau, and S.R. Carding. 1998. Mechanisms of intestinal epithelial cell injury and colitis interleukin 2 (IL2)-deficient mice. Cell. Immunol. 187:52-66.
38. Guy-Grand, D., J.P. Di Santo, P. Henchoz, M. Malassis-Seris, and P. Vassalli. 1998. Small bowel enteropathy: role of intraepithelial lymphocytes and of cytokines (IL-12, IFN-gamma, TNF) in the induction of epithelial cell death and renewal. Eur. J. Immunol. 28:730-744.
39. Piguet, P.F., C. Vesin, J. Guo, Y. Donati, and C. Barazzone. 1998. TNF-induced enterocyte apoptosis in mice is mediated by the TNF receptor 1 and does not require p53. Eur. J. Immunol. 28:3499-3505.
40. Saren, P., H.G. Welgus, and P.T. Kovanen. 1996. TNF-α and IL-1β selectively induce expression of 92-kDa gelatinase by human macrophages. J. Immunol. 157:4159-4165.
41. Pender, S.L., S.P. Tickle, A.J. Docherty, D. Howie, N.C. Wathen, and T.T. MacDonald. 1997. A major role for matrix metalloproteinases in T cell injury in the gut. J. Immunol. 158:1582-1590.
42. Reinecker, H.C., M. Steffen, C. Doehn, J. Petersen, I. Pfluger, A. Voss, and A. Raedler. 1991. Proinflammatory cytokines in intestinal mucosa. Immunol. Res. 10:247-248.
43. Cella, M., A. Engering, V. Pinet, J. Pieters, and A. Lanzavecchia. 1997. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature. 388: 782-787.
44. Riminton, D.S., H. Korner, D.H. Strickland, F.A. Lemckert, J.D. Pollard, and J.D. Sedgwick. 1998. Challenging cytokine redundancy: inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, mice. J. Exp. Med. 187:1517-1528.
45. Mackay, F., J.L. Browning, P. Lawton, S.A. Shah, M. Comiskey, A.K. Bhan, E. Mizoguchi, C. Terhorst, and S.J. Simpson. 1998. Both the lymphotoxin and tumor necrosis factor pathways are involved in experimental murine models of colitis. Gastroenterology. 115:1464-1475.
46. Stabila, P.F., S.C. Wong, F.A. Kaplan, and W. Tao. 1998. Cell surface expression of a human IgG Fc chimera activates macrophages through Fc receptors. Nat. Biotechnol. 16:1357-1360.
47. Korner, H., D.S. Riminton, D.H. Strickland, F.A. Lemckert, J.D. Pollard, and J.D. Sedgwick. 1997. Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting. J. Exp. Med. 186:1585-1590.
48. Bregenholt, S., and M.H. Claesson. 1998. Increased intracellular Th1 cytokines in scid mice with inflammatory bowel disease. Eur. J. Immunol. 28:379-389.
49. Grewal, I.S., and R.A. Flavell. 1998. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16:111-135.